- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02277821
Evaluation of Stendo Pulsating Suit on Microcirculation and Central Blood Pressure in Essential Hypertension Patients
Evaluation of the Action of the Stendo Pulsating Suit on Peripheral Microcirculation and on Central Blood Pressure in Essential Hypertension Patients Treated But Not Stabilized
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The role of the endothelium in micro-vascular system is mediated by synthesis and release of numerous substances that act on the smooth muscle fibres. The release of these products is modulated, in turn, by various circulating molecules, by the autonomic nervous system and by local mechanical factors such as shear stress.
The essential hypertension is associated to increased risks of cardiovascular and stroke morbidity and mortality and constitutes a major cause of severe kidney failure. The essential hypertension is a complex and multi-factorial disease; the dysfunction of the endothelium is of a great importance in the physiopathology of this disease, concerning both the consequences of the increase of the blood pressure and the possible cause of the hypertension development.
The Stendo pulsating suit is expected to increase the cutaneous microcirculation measured by laser Doppler laser flowmetry and potentially to decrease the central blood pressure. Each patient will be his own witness and the clinical records will be assessed before, during when relevant, and after a pulsating suit session.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Guy AMAH, MD
- Phone Number: +331 49 95 80 88
- Email: guy.amah@lrb.aphp.fr
Study Locations
-
-
-
Paris, France, 75010
- Recruiting
- Hôpital Lariboisière - Service de Physiologie Clinique - Explorations Fonctionnelles
-
Contact:
- Guy AMAH, MD
- Phone Number: +33 1 49 95 80 88
- Email: guy.amah@lrb.aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient referred to the Hypertension Hospital Consultation for essential hypertension treated but not stabilized
- Patient with essential hypertension defined by a brachial arterial pressure of 140 ≤ Systolic Arterial Pressure < 180 mm Hg and/or 90 ≤ Diastolic Arterial - Pressure < 110 mm Hg
- Essential Hypertension confirmed by an ambulatory measure of the arterial pressure during 24 hours before the pre-inclusion visit
- Patients aged more than 40 and less than 70
Exclusion Criteria:
- Patient with secondary hypertension
- Patient with diabetes
- Patient with complete arrhythmia with atrial fibrillation
- Patient with an advanced obstructive arterial disease
- Patient with a recent and progressive deep venous thrombosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Stendo pulsating suit System
One 20 minutes Stendo pulsating suit session will be applied to the patient.
|
The Stendo system, a multilayer pulsatile inflatable suit is applied to the lower limbs and the abdomen.
This device induces a sequential compartmentalized compression synchronized with each diastolic phase of the cardiac cycle, each phase evolving centripetally (lower limbs to abdomen).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peripheral microcirculation measured using Laser Doppler flowmetry
Time Frame: 35 minutes after the end of the Stendo session at D1 + 7 jours +/- 3
|
Change in % of the peripheral cutaneous microcirculation using laser Doppler flowmetry after one Stendo pulsating suit session
|
35 minutes after the end of the Stendo session at D1 + 7 jours +/- 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Humeral arterial pressure
Time Frame: 20 minutes after the end of Stendo session at D1 + 7 jours +/- 3
|
Humeral arterial pressure using automatic measures with Dinamap device
|
20 minutes after the end of Stendo session at D1 + 7 jours +/- 3
|
Central blood pressure
Time Frame: Just after the end of the Stendo session.at D1 + 7 jours +/- 3
|
Central blood pressure measured by applanation using an applanation tonometry device; Central pulse pressure, Augmentation Index and subendocardial viability ratio will also be assessed.
|
Just after the end of the Stendo session.at D1 + 7 jours +/- 3
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Guy AMAH, MD, Service de Physiologie Clinique - Explorations Fonctionnelles
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014-A00804-43
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Essential Hypertension
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Addpharma Inc.Completed
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
BayerCompletedHypertension, EssentialGermany
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
Addpharma Inc.Not yet recruitingHypertension,Essential
-
Instituto de Cardiologia do Rio Grande do SulRecruitingHypertension | Hypertension,EssentialBrazil
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto Alegre; Leonhardt Ventures LLCNot yet recruitingHypertension | Hypertension,Essential
Clinical Trials on Stendo pulsating suit System
-
StendoCompletedPrimary Lower Limb Lymphedema | Secondary Lower Limb LymphedemaFrance
-
Tampere University HospitalCompleted
-
Oslo University HospitalUnknown
-
Calliditas Therapeutics ABArchimedes Development LtdCompletedIGA NephropathySweden